Modified vaccinia virus Ankara delivers a robust surrogate marker for immune monitoring to sarcoma cells even if cells are being exposed to chemotherapy and heat treatment.

Tschoep-Lechner, Katharina

Modified vaccinia virus Ankara delivers a robust surrogate marker for immune monitoring to sarcoma cells even if cells are being exposed to chemotherapy and heat treatment. [electronic resource] - International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2012 - 33-42 p. digital

Publication Type: Journal Article

1464-5157

10.3109/02656736.2011.626834 doi


Antigen Presentation
Antineoplastic Agents, Alkylating--pharmacology
Cell Line, Tumor
Cell Survival
Green Fluorescent Proteins--immunology
Hot Temperature
Humans
Ifosfamide--pharmacology
Interferon-gamma--immunology
Monophenol Monooxygenase--genetics
Sarcoma--immunology
T-Lymphocytes, Cytotoxic--immunology
Transduction, Genetic
Tumor Cells, Cultured
Vaccinia--immunology
Vaccinia virus--genetics